跳至主要内容
临床试验/IRCT201211179855N2
IRCT201211179855N2已完成未知

Randomized, Double-Blind, Placebo-Controlled Trial of L-Arginine Supplementation for the treatment of pulmonary Tuberculosis

Arak University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 99 years(—)
性别
All

入选标准

  • adults over 15 years ;New cases of positive sputum smear
  • Exclusion criteria: pregnant women ; aged under 15 years, ;patients who During the past month received L-arginine ; Sensitivity to L - arginine

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
不适用
Ferric Carboxymaltose Versus Placebo in Patients with Congestive Heart Failure
EUCTR2012-001134-33-DEniversitätsklinikum Ulm
招募中
4 期
Randomized, Double-Blind, Placebo-Controlled Trial of 6 Months versus 12 Months Clopidogrel Therapy After Implantation Of A Drug-Eluting Stent Intracoronary Stenting and Antithrombotic Regimen:Safety And Efficacy of Six-Months Dual Antiplatelet Therapy After Drug-Eluting StentingI20I21I22I23I24I25Angina pectorisSubsequent myocardial infarctionCertain current complications following acute myocardial infarctionOther acute ischaemic heart diseasesChronic ischaemic heart diseaseAcute myocardial infarction
DRKS00000132Klinik für Herz-und KreislauferkrankungenDeutsches Herzzentrum München6,000
Enrolling By Invitation
4 期
Adjunctive vitamin d2 supplement in patient with allergen-specific immunotherapy randomized, double-blind, placebo-controlled trialPatients with allergic rhinitis and asthma begin treatment with allergen-specific immunotherapy.Calciferol, Vitamin D2 , allergic rhinitis, asthma, allergen-specific immunotherapy, TNSS score, ACT score, PEFR, Absolute eosinophil
TCTR20190813001Phramongkutklao Medicine Foundation30
尚未招募
不适用
Project goal is eliminate HIV within all systems of the body and to prevent its transmission.HIV/AIDSupper respiratory tract infectionsTuberculosisMalaria
PACTR201401000720267Health Gateway (PTY) Ltd200
进行中(未招募)
1 期
APatients suffering from unilateral lateral epicondylitis, persistent for more than 3 months or recurrent and not having responded to at least one reference treatmentMedDRA version: 20.0 Level: PT Classification code 10014971 Term: Epicondylitis System Organ Class: 10022117 - Injury, poisoning and procedural complications
EUCTR2017-001709-33-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)150
Effectivenessof L-Arginine supplementation for... | 临床试验